Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India.

Transactions of the Royal Society of Tropical Medicine and Hygiene - 8 Apr 2020

Desikan Prabha, Panwalkar Nikita, Chaudhuri Shreya, Khan Zeba, Punde Ram Prakash, Pauranik Ankur, Mirza Shaina Beg, Ranjan Rajeev, Anand Sridhar, Sachdeva K S

Abstract excerpt

BACKGROUND: Drug-resistant TB is a serious public health problem in India. Pre-existing resistance to fluoroquinolones (FQs) and second-line injectable drugs (SLIDs) in strains of Mycobacterium tuberculosis (MTB) resistant to rifampicin (RIF) and/or isoniazid (INH) contributes to treatment failures and consequent transmission of drug-resistant TB. A baseline assessment of resistance of MTB to FQs and SLIDs may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Fluoroquinolones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microbial Sensitivity Tests

Share to Mutation

Share to Mycobacterium tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 32003797
DOI: 10.1093/trstmh/trz121

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Burden of baseline resistance of Mycobacterium tuberculosis to fluoroquinolones and second-line injectables in central India.PMID 32003797Read ↗

Genotypic Characterization of Drug Resistance-associated Mutations in Mycobacterium tuberculosis Using Line Probe Assays in Central India.Semantic proximity Read ↗

Second Line Injectable Drug Resistance and Associated Genetic Mutations in Newly Diagnosed Cases of Multidrug-Resistant Tuberculosis.Semantic proximity Read ↗

Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.Semantic proximity Read ↗

Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay.Semantic proximity Read ↗

Drug resistance and associated genetic mutations among patients with suspected MDR-TB in Uttar Pradesh, India.Semantic proximity Read ↗

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.Semantic proximity Read ↗

Direct detection of resistance to fluoroquinolones/SLIDs in sputum specimen by GenoType MTBDRsl v.2.0 assay A study from Eastern Uttar Pradesh, India.Semantic proximity Read ↗

Prevalence and factors associated with multidrug-resistant tuberculosis in South India.Semantic proximity Read ↗

Second-line Drug Resistance Characterization in Mycobacterium tuberculosis by Genotype MTBDRsl Assay.Semantic proximity Read ↗

Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.Semantic proximity Read ↗

Novel rrs mutations in second-line injectable drug-resistant clinical isolates of Mycobacterium tuberculosis from the Punjab province of Pakistan.Semantic proximity Read ↗

Drug resistance patterns and treatment outcomes in DR-TB patients at a tertiary care centre in Mumbai.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.